SCHEMBL723135

SCHEMBL723135

C=CCCCCCCC(C)C(=O)O

nearest known ligand 0.50

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
MAPT P10636 3/20 0.50
ABCC4 O15439 1/20 0.50
ACE2 Q9BYF1 1/20 0.48
LTA4H P09960 1/20 0.47
BLM P54132 1/20 0.47
ALDH1A1 P00352 3/20 0.45
USP2 O75604 2/20 0.45
CYP3A4 P08684 2/20 0.45
SMN1; SMN2 Q16637 2/20 0.45
HPGD P15428 1/20 0.45
LMNA P02545 2/20 0.44
GABRR1 P24046 2/20 0.43
CYP1A2 P05177 1/20 0.43
TBXAS1 P24557 2/20 0.41
TSHR P16473 1/20 0.41
RECQL P46063 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29092238 1.00 MAPT (0.50) MAPTABCC4ACE2LTA4HBLM
SCHEMBL11928905 1.00 MAPT (0.50) MAPTABCC4ACE2LTA4HBLM
SCHEMBL7560013 1.00 MAPT (0.50) MAPTABCC4ACE2LTA4HBLM
SCHEMBL5606659 1.00 MAPT (0.50) MAPTABCC4ACE2LTA4HBLM
SCHEMBL11747978 1.00 MAPT (0.50) MAPTABCC4ACE2LTA4HBLM
SCHEMBL1524396 1.00 MAPT (0.50) MAPTABCC4ACE2LTA4HBLM
SCHEMBL3121221 1.00 MAPT (0.50) MAPTABCC4ACE2LTA4HBLM
SCHEMBL7558719 1.00 MAPT (0.50) MAPTABCC4ACE2LTA4HBLM
SCHEMBL5956346 1.00 MAPT (0.50) MAPTABCC4ACE2LTA4HBLM
SCHEMBL1121905 1.00 MAPT (0.50) MAPTABCC4ACE2LTA4HBLM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 294 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4464686-B1 PROCESS FOR THE PREPARATION OF AN ACETAL FROM AN OLEFIN USING TTI2 OR PTBR2 EVONIK OXENO GMBH & CO KG (DE) 2025-07-16 EP claimed
EP-4464687-B1 PROCESS FOR THE PREPARATION OF AN ACETAL FROM AN OLEFIN USING AN IODINE ALKYL COMPOUND EVONIK OXENO GMBH & CO KG (DE) 2025-07-09 EP claimed
EP-4464686-A1 PROCESS FOR THE PREPARATION OF AN ACETAL FROM AN OLEFIN USING TTI2 OR PTBR2 Evonik Oxeno GmbH & Co. KG (DE) 2024-11-20 EP claimed
EP-4464687-A1 PROCESS FOR THE PREPARATION OF AN ACETAL FROM AN OLEFIN USING AN IODINE ALKYL COMPOUND Evonik Oxeno GmbH & Co. KG (DE) 2024-11-20 EP claimed
EP-3377465-B1 PRODUCTION OF FATTY OLEFIN DERIVATIVES VIA OLEFIN METATHESIS PROVIVI INC (US) 2023-08-02 EP claimed
EP-1501784-B1 INTEGRATED CHEMICAL PROCESSES FOR INDUSTRIAL UTILIZATION OF SEED OILS DOW GLOBAL TECHNOLOGIES LLC (US) 2019-03-13 EP claimed
EP-2941415-B1 CROSS METATHESIS PROCESS ARKEMA FRANCE (FR) 2017-04-26 EP claimed
EP-2941413-B1 PROCESS FOR THE SYNTHESIS OF OMEGA-UNSATURATED NITRILE-ACID/ESTER IN WHICH TWO TYPES OF CROSS METATHESIS ARE ALTERNATED CONSECUTIVELY, SWING PROCESS ARKEMA FRANCE (FR) 2016-10-19 EP claimed
US-20160046885-A1 BRANCHED POLYMERS AS VISCOSITY AND/OR FRICTION MODIFIERS FOR LUBRICANTS BATTELLE MEMORIAL INSTITUTE (US) 2016-02-18 US claimed
US-20150368180-A1 ACID CATALYZED OLIGOMERIZATION OF ALKYL ESTERS AND CARBOXYLIC ACIDS ELEVANCE RENEWABLE SCIENCES, INC. (US) 2015-12-24 US claimed
WO-2011008258-A2 CATALYSTS AND PROCESSES FOR THE FORMATION OF TERMINAL OLEFINS BY ETHENOLYSIS MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) 2011-01-20 WO claimed
EP-1810960-B1 Method of co-producing olefins and diesters or diacids from unsaturated fatty bodies INST FRANCAIS DU PETROLE (FR) 2009-11-18 EP claimed
EP-1377537-B1 METATHESIS OF UNSATURATED FATTY ACID ESTERS OR UNSATURATED FATTY ACIDS WITH LOWER OLEFINS DOW GLOBAL TECHNOLOGIES INC (US) 2009-04-22 EP claimed
EP-1673328-B1 AN IMPROVED PROCESS FOR THE SYNTHESIS OF UNSATURATED ALCOHOLS DOW GLOBAL TECHNOLOGIES INC (US) 2008-07-09 EP claimed
EP-1626999-B1 OLEFIN POLYMERIZATION CATALYST SYSTEM USEFUL FOR POLAR MONOMERS EXXONMOBIL CHEM PATENTS INC (US) 2007-09-26 EP claimed
US-7119216-B2 Metathesis of unsaturated fatty acid esters or unsaturated fatty acids with lower olefins DOW GLOBAL TECHNOLOGIES INC. (US) 2006-10-10 US claimed
US-20050070750-A1 Metathesis of unsaturated fatty acid esters or unsaturated fatty acids with lower olefins DOW GLOBAL TECHNOLOGIES LLC 2005-03-31 US claimed
EP-1377537-A1 METATHESIS OF UNSATURATED FATTY ACID ESTERS OR UNSATURATED FATTY ACIDS WITH LOWER OLEFINS DOW GLOBAL TECHNOLOGIES INC. (US) 2004-01-07 EP claimed
WO-2002076920-A1 METATHESIS OF UNSATURATED FATTY ACID ESTERS OR UNSATURATED FATTY ACIDS WITH LOWER OLEFINS DOW GLOBAL TECHNOLOGIES INC. (US) 2002-10-03 WO claimed
EP-0057736-B1 OLEFIN DISPROPORTIONATION PROCESS AND CATALYST PHILLIPS PETROLEUM COMPANY (US) 1986-11-20 EP claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050070750-A1 Metathesis of unsaturated fatty acid esters or unsaturated fatty acids with lower olefins ALOX12, ALOX15, ALOX5 MAPT 3299/4885ABCC4 4255/4885ACE2 3841/4885
US-20150368180-A1 ACID CATALYZED OLIGOMERIZATION OF ALKYL ESTERS AND CARBOXYLIC ACIDS DECR2, SCD, FASN MAPT 2093/4885ABCC4 4114/4885ACE2 3179/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.